It may be helpful for patients with chronic injuries, digestive issues, or other conditions that havent responded well to standard treatments
With prolonged or high-dose use, receptors may become less responsive, making the peptide less effective
As a glucagon-like peptide-1 ( GLP-1 ) receptor agonist, it works by mimicking the natural GLP-1 hormone in the body and, in doing so, delays gastric emptying (i.e
143,144,145 The relative abundance of the gut microbiota is dynamic
Evidence suggests that patients with permanent or transient NDM due to mutations in KCNJ11 or ABCC8 gene were successfully treated with SU (GLIB) therapy rather than insulin.[169,170,171,172] An observational case study reported that young children with neonatal diabetes even with blood glucose level of 350 mg/dL also responded to a usual dose of SU.[173] Pregnancy and lactation Second-generation SUs such as GLIB despite low molecular weight do not cross the placenta in significant amounts.[174] This phenomenon may be attributed either to its high protein-binding capacity (99.8%) or reverting the total GLIB content into the maternal system by an unidentified placental transport system
